
|Articles|November 11, 2007
Medical adjuvant therapy may not be beneficial for macular hole surgery
The use of medical adjuvant therapy for macular holes during vitreous surgery seems to be decreasing in macular hole surgery, said Alain Gaudric, MD, of Lariboisière Hospital, Paris.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: Updates on tinlarebant in adolescent Stargardt disease
2
Macular laser picks up speed: The technology accelerating retinal therapies
3
FLORetina 2025: Enrico Borrelli on reframing retinal disease through the lens of choroidal health
4
FLORetina 2025: Long-term follow-up in paediatric gene therapy
5












































